UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Standardprozesse ambulanter psychosozialer Krebsberatung: Ein Beitrag der Landeskrebsgesellschaften zur Qualitätssicherung des Beratungsprozesses

Forum (Heidelberg), 2019-12, Vol.34 (6), p.527-536

2019

Volltextzugriff (PDF)

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines

Leukemia, 1999-11, Vol.13 (11), p.1864-1872

1999

Volltextzugriff (PDF)

Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage

Leukemia, 1999-11, Vol.13 (11), p.1859-1863

1999

Volltextzugriff (PDF)

Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial

Haematologica (Roma), 2004-03, Vol.89 (3), p.371

2004

Volltextzugriff (PDF)

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Leukemia, 1997-12, Vol.11 Suppl 5, p.S1

1997

Volltextzugriff (PDF)

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Leukemia, 1998-07, Vol.12 (7), p.1009-1012

1998

Volltextzugriff (PDF)

P-glycoprotein expression in patients with acute leukemia : Clinical relevance

Leukemia, 1996-07, Vol.10, p.S23-S31

1996

Volltextzugriff (PDF)

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

Leukemia, 1996, Vol.10 (7), p.1177-1180

1996

Volltextzugriff (PDF)

Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma

Leukemia, 1997-12, Vol.11 Suppl 5, p.S22

1997

Volltextzugriff (PDF)

Functional P-gp expression in multiple myeloma patients at primary diagnosis and relapse or progressive disease

Leukemia, 1997-12, Vol.11 Suppl 5, p.S10-S14

1997

Volltextzugriff (PDF)

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

Leukemia, 1996-07, Vol.10, p.S46-S49

1996

Volltextzugriff (PDF)

Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding

Annals of hematology, 1994-07, Vol.69 Suppl 1 (1), p.S13-S17

1994

Volltextzugriff (PDF)

Idarubicin monotherapy in multiply pretreated leukemia patients : response in relation to P-glycoprotein expression

Annals of hematology, 1997-02, Vol.74 (2), p.57-64

1997

Volltextzugriff (PDF)

Intermittent exposure to doxorubicin in vitro selects for multifactorial non‐P‐glycoprotein‐associated multidrug resistance in RPMI 8226 human myeloma cells

British journal of haematology, 1997-04, Vol.97 (1), p.65-75

1997

Volltextzugriff (PDF)

In Vitro Efficacy of Known P-Glycoprotein Modulators Compared to Droloxifene E and Z: Studies on a Human T-Cell Leukemia Cell Line and their Resistant Variants

Leukemia & lymphoma, 1998, Vol.31 (5-6), p.589-597

1998

Volltextzugriff (PDF)

Nuclear Topoisomerase II Activity Changes During HL-60 Leukemic Cell Differentiation: Alterations in Drug Sensitivity and pH Dependency

Leukemia & lymphoma, 1991, Vol.5 (4), p.273-279

1991

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(16)

Sprache

Englisch
(15)
Deutsch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Standardprozesse ambulanter psychosozialer Krebsberatung: Ein Beitrag der Landeskrebsgesellschaften zur Qualitätssicherung des Beratungsprozesses

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines

Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage

Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

P-glycoprotein expression in patients with acute leukemia : Clinical relevance

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma

Functional P-gp expression in multiple myeloma patients at primary diagnosis and relapse or progressive disease

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding

Idarubicin monotherapy in multiply pretreated leukemia patients : response in relation to P-glycoprotein expression

Intermittent exposure to doxorubicin in vitro selects for multifactorial non‐P‐glycoprotein‐associated multidrug resistance in RPMI 8226 human myeloma cells

In Vitro Efficacy of Known P-Glycoprotein Modulators Compared to Droloxifene E and Z: Studies on a Human T-Cell Leukemia Cell Line and their Resistant Variants

Nuclear Topoisomerase II Activity Changes During HL-60 Leukemic Cell Differentiation: Alterations in Drug Sensitivity and pH Dependency

Aktive Filter

Suchergebnisse filtern